Found: 8
Select item for more details and to access through your institution.
A full-document analysis of the semantic relation between European Public Assessment Reports and EMA guidelines using a BERT language model.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0294560
- By:
- Publication type:
- Article
The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies.
- Published in:
- Therapeutic Advances in Rare Disease, 2023, v. 4, p. 1, doi. 10.1177/26330040231188979
- By:
- Publication type:
- Article
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In-frame Exon Skipping in KRT5 due to Novel Intronic Deletion Causes Epidermolysis Bullosa Simplex, Generalized Severe.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis.
- Published in:
- Clinical Epidemiology, 2023, v. 15, p. 923, doi. 10.2147/CLEP.S418069
- By:
- Publication type:
- Article
International regulatory and publicly-funded initiatives to advance drug repurposing.
- Published in:
- Frontiers in Medicine, 2024, p. 01, doi. 10.3389/fmed.2024.1387517
- By:
- Publication type:
- Article
Drug repurposing for rare: progress and opportunities for the rare disease community.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1352803
- By:
- Publication type:
- Article
Drug repurposing for rare: progress and opportunities for the rare disease community.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1352803
- By:
- Publication type:
- Article